AAAAAA
Results:
1-7
|
Results: 7
Authors:
Frustaci, S
Gherlinzoni, F
De Paoli, A
Bonetti, M
Azzarelli, A
Comandone, A
Olmi, P
Buonadonna, A
Pignatti, G
Barbieri, E
Apice, G
Zmerly, H
Serraino, D
Picci, P
Citation: S. Frustaci et al., Adjuvant chemotherapy for adult soft tissue sarcomas of the extremities and girdles: Results of the Italian randomized cooperative trial, J CL ONCOL, 19(5), 2001, pp. 1238-1247
Authors:
Frustaci, S
Buonadonna, A
La Mura, N
Libra, M
Citation: S. Frustaci et al., Chemotherapy, TUMORI, 87(4), 2001, pp. S9-S10
Authors:
Crivellari, D
Magri, MD
Buonadonna, A
Lombardi, D
Paolello, C
De Cicco, M
Fantin, D
Veronesi, A
Citation: D. Crivellari et al., Continuous infusion fluorouracil in the management of advanced breast cancer: A phase II study, TUMORI, 86(1), 2000, pp. 42-45
Authors:
Pagani, O
Sessa, C
Martinelli, G
Crivellari, D
Buonadonna, A
Thurlimann, B
Hess, D
Borner, M
Bauer, J
Zampino, G
Zimatore, M
Graffeo, R
Riva, A
Goldhirsch, A
Citation: O. Pagani et al., Dose-finding study of epidoxorubicin and docetaxel as first-line chemotherapy in patients with advanced breast cancer, ANN ONCOL, 10(5), 1999, pp. 539-545
Authors:
Frustaci, S
Buonadonna, A
Romanini, A
Comandone, A
Dalla Palma, M
Gamucci, T
Verusio, C
Lionetto, R
Dani, C
Casali, P
Santoro, A
Citation: S. Frustaci et al., Increasing dose of continuous infusion ifosfamide and fixed dose of bolus epirubicin in soft tissue sarcomas. A study of the Italian group on rare tumors, TUMORI, 85(4), 1999, pp. 229-233
Authors:
Lo Re, G
Buonadonna, A
Duati, M
Colussi, AM
Canzonieri, V
Frustaci, S
Morassut, S
Cimitan, M
Tumolo, S
Citation: G. Lo Re et al., Efficacy of total androgen blockade in metastatic prostatic carcinoma withtransient hypogonadotropic hypogonadism: A case report, TUMORI, 85(4), 1999, pp. 280-283
Authors:
Cannizzaro, R
Crivellari, D
Robieux, I
Sorio, R
Buonadonna, A
Citation: R. Cannizzaro et al., Anthracycline dose and liver dysfunction, BR J CANC, 79(11-12), 1999, pp. 1943-1943
Risultati:
1-7
|